Albash, R.; Ali, S.K.; Abdelmonem, R.; Agiba, A.M.; Aldhahri, R.; Saleh, A.; Kassem, A.B.; Abdellatif, M.M.
Electrospun Nanofiber-Scaffold-Loaded Levocetirizine Dihydrochloride Cerosomes for Combined Management of Atopic Dermatitis and Methicillin-Resistant Staphylococcus Aureus (MRSA) Skin Infection: In Vitro and In Vivo Studies. Pharmaceuticals 2025, 18, 633.
https://doi.org/10.3390/ph18050633
AMA Style
Albash R, Ali SK, Abdelmonem R, Agiba AM, Aldhahri R, Saleh A, Kassem AB, Abdellatif MM.
Electrospun Nanofiber-Scaffold-Loaded Levocetirizine Dihydrochloride Cerosomes for Combined Management of Atopic Dermatitis and Methicillin-Resistant Staphylococcus Aureus (MRSA) Skin Infection: In Vitro and In Vivo Studies. Pharmaceuticals. 2025; 18(5):633.
https://doi.org/10.3390/ph18050633
Chicago/Turabian Style
Albash, Rofida, Samer Khalid Ali, Rehab Abdelmonem, Ahmed M. Agiba, Renad Aldhahri, Asmaa Saleh, Amira B. Kassem, and Menna M. Abdellatif.
2025. "Electrospun Nanofiber-Scaffold-Loaded Levocetirizine Dihydrochloride Cerosomes for Combined Management of Atopic Dermatitis and Methicillin-Resistant Staphylococcus Aureus (MRSA) Skin Infection: In Vitro and In Vivo Studies" Pharmaceuticals 18, no. 5: 633.
https://doi.org/10.3390/ph18050633
APA Style
Albash, R., Ali, S. K., Abdelmonem, R., Agiba, A. M., Aldhahri, R., Saleh, A., Kassem, A. B., & Abdellatif, M. M.
(2025). Electrospun Nanofiber-Scaffold-Loaded Levocetirizine Dihydrochloride Cerosomes for Combined Management of Atopic Dermatitis and Methicillin-Resistant Staphylococcus Aureus (MRSA) Skin Infection: In Vitro and In Vivo Studies. Pharmaceuticals, 18(5), 633.
https://doi.org/10.3390/ph18050633
